-
Mashup Score: 0Covid antiviral’s MTX block - Rheuma - 3 year(s) ago
Molnupiravir is now PBS-listed, but rheum patients get left behind yet again in the race for covid protection in Australia.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Access concerns for “game-changing” covid therapy - Rheuma - 3 year(s) ago
The TGA’s provisional approval of Australia’s first covid prevention therapy has been welcomed, but many eligible patients may miss out.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2Antidepressant turns volume down on knee OA in trial - Rheuma - 3 year(s) ago
Study finds duloxetine helps reduce central sensitisation-linked knee OA pain, but trial shortcomings leave unanswered questions.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0OPAL Year in Review 2021 - Rheuma - 3 year(s) ago
This article outlines the 2021 research outputs of OPAL Rheumatology, highlighting the collaborative efforts of OPAL’s researchers, rheumatologists and their patients
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1
But supply issues mean tough decisions for physicians.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Rates and predictors of MTX side effects - Rheuma - 3 year(s) ago
A large study in early RA patients could help guide patients to make informed decisions about taking the drug and potentially increase adherence.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Predicting early RA on MRI - Rheuma - 3 year(s) ago
MRI-detected tenosynovitis predicts RA developing within a year, potentially preventing overtreatment.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Is telehealth widening the disadvantage gap? - Rheuma - 3 year(s) ago
Telehealth is creating health care disparities for patients who are poorer, older and culturally and linguistically diverse, researchers have found.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0The year ahead in rheumatology - Rheuma - 3 year(s) ago
What will 2022 hold for rheumatology clinicians and patients? New therapeutics, more real-world evidence studies and, of course, more covid.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 12Internships at The Medical Republic • The Medical Republic - 3 year(s) ago
The Medical Republic is offering paid internships for those keen to join our team publishing news and magazines for Australian doctors. We have a Sydney office, but remote or hybrid internships may also be possible. Students, recent graduates and other keen applicants can express interest by emailing a CV and a writing sample to ruby@medicalrepublic.com.au…. View Article
Source: The Medical RepublicCategories: Latest Headlines, RheumatologyTweet
Molnupiravir is now PBS-listed for people at high risk of severe covid, including immunocompromised, but there are concerns that rheum patients on MTX could miss out due to the high dosage criteria @KarinaBray7 https://t.co/eINyFKzful